CCL17 and CCL22 promote stemness of cancer cells with CCR4 expression [218], drug resistance [232], stimulate the proliferation of cancer cells [233], and cause cancer cell migration and EMT, as shown on many types of cancers [214,218,234]. This evidence concerns the gene CCR4 and cancer.